Channel: Drbeen Medical Lectures

Category: Entertainment

Description: Potential New Killer Cells for Cancer Immunotherapy This amazing find by the scientists from Memorial Sloan Kettering Cancer Center holds a lot of potential for immunotherapy of the solid tumors. Let's review If you like this content and want more, I am doing a special lifetime membership offer. Click here: drbeen.com/yt-special Want to support this work?: Buy me a coffee :-) buymeacoffee.com/DrMobeenSyed Become my patron: patreon.com/mobeensyed?fan_landing=true PayPal: paypal.me/mobeensyed?locale.x=en_US My substack: mobeensyedmd.substack.com #drbeen #koolbeens #CancerTherapy Disclaimer: This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only. Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional. URL list from Monday, Apr. 25 2022 FastStats - Older Persons Health cdc.gov/nchs/fastats/older-american-health.htm Trends in Causes of Death among Older Persons in the United States (October 2005) cdc.gov/nchs/data/ahcd/agingtrends/06olderpersons.pdf Cancer Immunosurveillance by Tissue-Resident Innate Lymphoid Cells and Innate-like T Cells: Cell cell.com/cell/fulltext/S0092-8674(16)00003-9 Programme of self-reactive innate-like T cell-mediated cancer immunity | Nature nature.com/articles/s41586-022-04632-1 Scientists identify potential new 'soldier' for cancer immunotherapy -- ScienceDaily sciencedaily.com/releases/2022/04/220420133616.htm About Us | Sloan Kettering Institute mskcc.org/research/ski/about New T cell immune response discovery points to ‘out-of-box’ cancer therapy options – Endpoints News endpts.com/new-t-cell-immune-response-discovery-points-to-out-of-box-cancer-therapy-options Programme of self-reactive innate-like T cell-mediated cancer immunity en.x-mol.com/paper/article/1516862209619566592 Immune Checkpoint Inhibitors - National Cancer Institute cancer.gov/about-cancer/treatment/types/immunotherapy/checkpoint-inhibitors nci-vol-10396-150.jpg (1500×1200) cancer.gov/sites/g/files/xnrzdm211/files/styles/cgov_enlarged/public/cgov_image/media_image/2019-09/nci-vol-10396-150.jpg?h=30063a04&itok=DGHB7TA1 Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors - PubMed pubmed.ncbi.nlm.nih.gov/29990692 Definition of CTLA-4 - NCI Dictionary of Cancer Terms - National Cancer Institute cancer.gov/publications/dictionaries/cancer-terms/def/ctla-4 776560.jpg (3120×2400) nci-media.cancer.gov/pdq/media/images/776560.jpg USCS Data Visualizations - CDC gis.cdc.gov/Cancer/USCS/#/Demographics FCER1G - Wikipedia en.wikipedia.org/wiki/FCER1G